Improved sleep efficiency after anti-tumor necrosis factor α therapy in rheumatoid arthritis patients

Therapeutic Advances in Musculoskeletal Disease

Volumn 3, Issue 5, 2011, Pages 227-233

  Taylor Gjevre, Regina M ^a   Gjevre, John A ^a   Skomro, Robert P ^a   Nair, Bindu V ^a   Lim, Hyun J ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

anti TNF; obstructive sleep apnea; polysomnogram; restless legs syndrome; rheumatoid arthritis; sleep

Indexed keywords

ADALIMUMAB; ETANERCEPT; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; AROUSAL; ARTICLE; BLOOD VESSEL PERFORATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG RESPONSE; EPWORTH SLEEPINESS SCALE; FATIGUE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HIGH RISK PATIENT; HUMAN; INSTRUMENT VALIDATION; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PITTSBURGH SLEEP QUALITY INDEX; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPEAT PROCEDURE; RESTLESS LEGS SYNDROME; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SHORT FORM 36; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP QUALITY; SLEEP STAGE; SLEEP TIME; SOMNOLENCE;

EID: 84857491219     PISSN: 1759720X     EISSN: 17597218     Source Type: Journal    
DOI: 10.1177/1759720X11416862     Document Type: Article

References (40)

1. Abad V.C. Sarinas P.S.A. Guilleminault C. (2008) Sleep and rheumatologic disorders. Sleep Med Rev 12: 211–228.
2. Allen R.P. Picchietti E. Hening A. Trenkwalder C. Walters A.S. Montplaisi J. (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4: 101–119.
3. American Academy of Sleep Medicine Task Force (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22: 667–689.
4. Buysse D.J. Reynolds C.F.I. Monk T.H. Berman S.R. Kupfer D.J. (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28: 193–213.
5. Campbell M.J. Julious S.A. Altman D.G. (1995) Estimating sample sizes for binary, ordered categorical and continuous outcomes in two group comparisons. BMJ 311: 1145–1148.
6. Cappuccio F.P. D'Elia L. Strazzullo P. Miller M.A. (2010) Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 33: 585–592.
7. Carskadon M.A. Rechtschaffen A. (2000) Monitoring and staging human sleep. In: Ed. Kryger M.H. Roth T. Dement W. (eds) Principles and Practice of Sleep Medicine 3rd. W.B. Saunders: Philadelphia, PA, 1197–1215.
8. Chhangani B.S. Roehrs T.A. Harris E.J. Hyde M. Drake C. Hudgel D.W. et al (2009) Pain sensitivity in sleepy pain-free normals. Sleep 32: 1011–1017.
9. Ciftci T.U. Kokturk O. Bukan N. Bilgihan A. (2004) The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 28: 87–91.
10. Da Costa D. Zummer M. Fitzcharles M.A. (2009) Determinants of sleep problems in patients with spondyloarthopathy. Musculoskeletal Care 7: 143–161.
11. Drewes A.M. Nielsen K.D. Hansen B. Taagholt S.J. Bjerregârd K. Svendsen L. (2000) A longitudinal study of clinical symptoms and sleep parameters in rheumatoid arthritis. Rheumatology 39: 1287–1289.
12. Fransen J. Langenegger T. Michel B.A. Stucki G. (2000) Feasibility and validity of the RADAI, a self-administered rheumatoid arthritis disease activity index. Rheumatology 39: 321–327.
13. Himmerich H. Beitinger P.A. Fulda S. Wehrle R. Linseisen J. Wolfram G. et al (2006) Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy. Arch Intern Med 166: 1739–1743.
14. Hirsch M. Carlander B. Vergé M. Tafti M. Anava J.M. Billiard M. et al (1994) Objective and subjective sleep disturbances in patients with rheumatoid arthritis. Arthritis Rheum 37: 41–49.
15. Hirshkowitz M. (2004) Normal human sleep: an overview. Med Clin N Am 88: 551–565.
16. Iber C. Ancoli-Israel S. Chesson A. Quan S.F. for the American Academy of Sleep Medicine (2007) The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. American Academy of Sleep Medicine: Westchester.
17. Irwin M.R. Wang M. Campomayor C.O. Collado-Hidalgo A. Cole S. (2006) Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 166: 1756–1762.
18. Johns M.J. (1991) A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 14: 540–545.
19. Kapsimalis F. Richardson G. Opp M.R. Kryger M. (2005) Cytokines and normal sleep. Curr Opin Pulm Med 11: 481–484.
20. Krueger J.M. Majde J.A. (2003) Humoral links between sleep and the immune system. Ann NY Acad Sci 992: 9–20.
21. Knutson K.L. Rathouz P.J. Yan L.L. Lui K. Lauderdale D.S. (2007) Intra-individual daily and yearly variability in actigraphically recorded sleep measures: the CARDIA study. Sleep 30: 793–796.
22. LaRochelle J.S. Karp B.I. (2004) Restless legs syndrome due to interferon-alpha. Mov Disord 19: 730–731.
23. Littman A.J. White E. Satia J.A. Bowen D.J. Kristal A.R. (2006) Reliability and validity of 2 single-item measures of psychosocial stress. Epidemiology 17: 398–403.
24. Moldofsky H. (2010) Rheumatic manifestations of sleep disorders. Curr Opin Rheumatol 22: 59–63.
25. Montplaisir J. Nicolas A. Godbout R. Walters A. (2000) Restless legs syndrome and periodic limb movement disorder. In: Ed. Kryger M.H. Roth T. Dement W.C. (eds) Principles and Practice of Sleep Medicine 3rd. W.B. Saunders: Philadelphia, PA, 742–752.
26. Netzer N.C. Stoohs R.A. Netzer C.M. Clark K. Strohl K.P. (1999) Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131: 485–491.
27. Peker Y. Kraiczi H. Hedner J. Löth S. Johansson A. Bende M. (1999) An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 14: 179–184.
28. Pincus T. Summey J.A. Soraci S.A. Jr Wallston K.A. Hummon N.P. (1983) Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 26: 1346–1353.
29. Radloff L.S. (1977) The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Measurement 1: 385–401.
30. Reading S.R. Crowson C.S. Rodeheffer R.J. Fitz-Gibbon P.D. Maradit-Kremers H. Gabriel S.E. (2009) Do rheumatoid arthritis patients have a higher risk for sleep apnea. J Rheumatol 36: 1869–1872.
31. Riha R.L. Brander P. Vennelle M. McArdel N. Kerr S.M. Anderson N.H. et al (2005) Tumor necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnea–hypopnoea syndrome. Eur Respir J 26: 673–678.
32. Taylor-Gjevre R.M. Gjevre J.A. Nair B. Skomro R. Lim H.J. (2010) Hypersomnolence and sleep disorders in a rheumatic disease patient population. J Clin Rheumatol 16: 255–261.
33. Taylor-Gjevre R.M. Gjevre J.A. Nair B.V. Skomro R.P. Lim H.J. (2011) Components of sleep quality and sleep fragmentation in rheumatoid arthritis and osteoarthritis. Musculoskeletal Care, June 5; doi:10.1002/msc.208. [Epub ahead of print].
34. Taylor-Gjevre R.M. Gjevre J.A. Skomro R. Nair B. (2009) Restless legs syndrome in a rheumatoid arthritis patient cohort. J Clin Rheumatol 15: 12–15.
35. Vgontzas A.N. Zoumakis M. Papanicolaou D.A. Bixler E.O. Prolo P. Lin H.M. et al (2002) Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism 51: 887–892.
36. Ware J.E. Jr Gandek B. (1998) Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 51: 903–912.
37. Wells G. Li T. Kirwan J.R. Peterson J. Aletaha D. Boers M. et al (2009) Assessing quality of sleep in patients with rheumatoid arthritis. J Rheumatol 36: 2077–2086.
38. Wells G. Li T. Maxwell L. Maclean R. Tugwell P. (2008) Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation and quality of life following treatment with abatacept for rheumatoid arthritis. Ann Rheum Dis 67: 260–265.
39. Wolfe F. Michaud K. Li T. (2006) Sleep disturbance in patients with rheumatoid arthritis: evaluation by medical outcomes study and visual analog sleep scales. J Rheumatol 33: 1942–1951.
40. Zamarron C. Maceiras F. Mera A. Gomez-Reino J.J. (2004) Effect of the first infliximab infusion on sleep and alertness in patients with active rheumatoid arthritis. Ann Rheum Dis 63: 88–90.